Guardian Health
This is how seriously a patient’s skin colour can affect the quality of medical care they receive | Devi Sridhar
Research continues to expose stark racial disparities in pain treatment, with patients of color consistently receiving less adequate care than their white counterparts. The so-called "ethnicity pain gap" reflects deeply embedded biases in medical systems, whether conscious or not, that translate directly into worse health outcomes. Closing it will require structural reform, better training, and an honest reckoning with how race shapes clinical decision-making.
Read article →Medical Xpress
Almost half of dementia cases could be prevented—but change is needed
Nearly half of all dementia cases are preventable through addressing modifiable risk factors like physical inactivity, smoking, and social isolation — yet a major Curtin University review published in *The Lancet Healthy Longevity* finds that broad public health campaigns are failing to translate awareness into meaningful behavior change. The research highlights a critical gap between knowing what prevents dementia and actually getting people to act on it. Closing that gap will require more targeted, evidence-based interventions rather than blanket messaging campaigns.
Read article →Medical Xpress
More than 400 dead in DR Congo's spreading Ebola outbreak
The Ebola outbreak in the Democratic Republic of Congo has surpassed 400 deaths and shows no signs of containment, with the virus now reaching Kisangani, a major urban center nearly 370 miles from the epicenter. The spread to a densely populated city raises alarm among health officials, as urban environments dramatically accelerate transmission. Containment efforts face mounting pressure as the outbreak continues to extend its geographic reach.
Read article →Medical Xpress
FDA approves Tzield for children with new stage 3 type 1 diabetes
Sanofi's Tzield has received FDA accelerated approval to delay insulin loss in children aged 8 to 17 diagnosed with stage 3 type 1 diabetes — marking a significant expansion of the drug's approved use. The treatment works by preserving the body's remaining ability to produce insulin, potentially slowing disease progression at a critical window after diagnosis. For families navigating a new T1D diagnosis, the approval offers a meaningful therapeutic option where few have previously existed.
Read article →Medical Xpress
Special food additive that helps prevent weight gain is approved in the EU
A synthetic dietary fiber called inulin propionate ester (IPE) has received EU Novel Food approval, clearing a key regulatory hurdle for commercial use as a food additive. Developed by researchers at Imperial College London and the University of Glasgow, IPE mimics the satiety effects of a high-fiber diet, signaling fullness to the brain and reducing calorie overconsumption. The approval marks a significant step toward a science-backed, non-pharmaceutical tool for tackling obesity at scale.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →